Brenda Libby Coleman

Array ( [id] => 6387925 [patent_doc_number] => 20100317619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Selective Agents for Pain Suppression' [patent_app_type] => utility [patent_app_number] => 12/779449 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 50637 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317619.pdf [firstpage_image] =>[orig_patent_app_number] => 12779449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296375 [patent_doc_number] => 20100240640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => '(THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/779014 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240640.pdf [firstpage_image] =>[orig_patent_app_number] => 12779014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598297 [patent_doc_number] => 20100292210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Novel Compounds for A-Beta-Related Pathologies' [patent_app_type] => utility [patent_app_number] => 12/777602 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49936 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292210.pdf [firstpage_image] =>[orig_patent_app_number] => 12777602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598560 [patent_doc_number] => 20100292220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/769878 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20174 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292220.pdf [firstpage_image] =>[orig_patent_app_number] => 12769878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536713 [patent_doc_number] => 20100204207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Compounds and Methods for Treating Dyslipidemia' [patent_app_type] => utility [patent_app_number] => 12/763344 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67413 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204207.pdf [firstpage_image] =>[orig_patent_app_number] => 12763344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431163 [patent_doc_number] => 20120253038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'PROCESSES FOR THE SYNTHESIS OF BAZEDOXIFENE ACETATE AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/257996 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6018 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401629 [patent_doc_number] => 20100305093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Inhibitors of mTOR and Methods of Making and Using' [patent_app_type] => utility [patent_app_number] => 12/756374 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 183106 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305093.pdf [firstpage_image] =>[orig_patent_app_number] => 12756374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6322078 [patent_doc_number] => 20100196714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'PROCESS FOR PREPARING QUINOLINE COMPOUNDS AND PRODUCTS OBTAINED THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/755721 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11277 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196714.pdf [firstpage_image] =>[orig_patent_app_number] => 12755721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10070614 [patent_doc_number] => 09108957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => '3-[1,4]oxazepane-4-pyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 13/262396 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34085 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757476 [patent_doc_number] => 20120029190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/262608 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87809 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029190.pdf [firstpage_image] =>[orig_patent_app_number] => 13262608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466239 [patent_doc_number] => 20100190772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Substituted Azepine Derivatives As Serotonin Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 12/752601 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24084 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190772.pdf [firstpage_image] =>[orig_patent_app_number] => 12752601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560311 [patent_doc_number] => 08334375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Methods for the preparation of drospirenone' [patent_app_type] => utility [patent_app_number] => 12/752859 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9992 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12752859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909460 [patent_doc_number] => 08481524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'c-MET protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/751016 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33305 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591951 [patent_doc_number] => 08349827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds' [patent_app_type] => utility [patent_app_number] => 12/751332 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43453 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577751 [patent_doc_number] => 08343961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Substituted heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 12/751238 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30973 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744402 [patent_doc_number] => 20120022047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE' [patent_app_type] => utility [patent_app_number] => 13/260914 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5001 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022047.pdf [firstpage_image] =>[orig_patent_app_number] => 13260914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637779 [patent_doc_number] => 20100173894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'BENZAZEPINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/729026 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23112 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173894.pdf [firstpage_image] =>[orig_patent_app_number] => 12729026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8187184 [patent_doc_number] => 20120116074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'METHODS FOR THE PREPARATION OF [2-(8,9-DIOXO-2,6-DIAZABICYCLO[5.2.0]NON-1(7)-EN-2-YL)ETHYL]PHOSPHONIC ACID AND PRECURSORS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/256777 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9319 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116074.pdf [firstpage_image] =>[orig_patent_app_number] => 13256777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490301 [patent_doc_number] => 20110237568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'CRYSTALLINE FORMS' [patent_app_type] => utility [patent_app_number] => 12/726619 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6732 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237568.pdf [firstpage_image] =>[orig_patent_app_number] => 12726619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757473 [patent_doc_number] => 20120029189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/257224 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26169 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029189.pdf [firstpage_image] =>[orig_patent_app_number] => 13257224 [rel_patent_id] =>[rel_patent_doc_number] =>)